Featured
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
Manufacturing at Wacker’s biotech site in Amsterdam is scheduled to start in the first half of 2021.Contract Pharma Staff 11.24.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News | Supply Chain
Lonza and Be The Match BioTherapies Enter CGT Partnership
Will expand Vein-to-Vein Cell and Gene Therapy Supply Chain Network.Contract Pharma Staff 11.24.20
-
Bio News | Breaking News | Facilities | Industry News
Samsung Biologics Breaks Ground on 'Super Plant'
When completed, the CDMO says it will be the world's largest bio-manufacturing facility.Contract Pharma Staff 11.24.20
-
Breaking News | Facilities | Industry News | Injectables | Parenterals
ApiJect Systems Approved for $590 Million Loan
Supports building a U.S.-based facility with surge capacity to produce up to 3 billion single-dose prefilled plastic injectors per year.Contract Pharma Staff 11.24.20
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Syngene and 3DC Sign 5-year Collaboration
Partner on discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.Contract Pharma Staff 11.24.20
-
Drug Delivery | Drug Development
Inhaled Drug Delivery Technology Trends
The success of new inhaled medicines relies on the correct combination of formulation and device technology.Online Exclusives Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20
-
Breaking News | Facilities | Industry News
Abenza Upgrades Chemistry GMP Suites
Appoints new leadership at Bristol PA site.Contract Pharma Staff 11.24.20
-
Breaking News | Clinical Trials | Industry News
Merck Acquires OncoImmune for $425M
Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19.Contract Pharma Staff 11.24.20
-
Aseptic Processing | Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Fill/Finish | Industry News | Injectables | Lyophilization | Parenterals
Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
Construction currently underway; expected to be completed in 2021.Contract Pharma Staff 11.24.20
-
Pre-filled Syringes & Injectable Drug Trends
Pre-filled syringes have become a preferred format, as they make it easier to handle drugs and increase dos- ing accuracy.11.23.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
AstraZeneca’s AZD1222 Meets Primary Endpoint in COVID-19
Two different dosing regimens demonstrated efficacy with one showing vaccine efficacy of 90% with no serious safety events noted.Contract Pharma Staff 11.23.20
-
Breaking News | Drug Development | Trials & Filings
Regeneron's COVID-19 Antibody Cocktail Gets EUA
Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.Contract Pharma Staff 11.23.20
-
Breaking News | Collaborations & Alliances | Drug Development
Amgen Ends Cardio Alliance with Cytokinetics
Will transition the development and commercialization rights for omecamtiv mecarbil to Cytokinetics and Servier.Contract Pharma Staff 11.23.20
-
Breaking News | cGMP Manufacture | Industry News
Catalent, Blueprint Enter GAVRETO Commercial Supply Pact
Following FDA approval and tech transfer, the Catalent team in Kansas City will support commercial supply of the non-small cell lung cancer drug.Contract Pharma Staff 11.23.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track
Initiation of ASPEN-COVID-19 Phase 2b clinical trial anticipated in December with trial data anticipated 2Q21.Contract Pharma Staff 11.23.20
- CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
- Merck Acquires OncoImmune for $425M
- ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track
- Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine
- Samsung Biologics Partners with Eli Lilly
- Delpharm to Manufacture Pfizer/BioNTech mRNA Vax in France
- Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study
- Almac Gets Grant From COVID-19 Therapeutics Accelerator
- DCAT President Talks COVID-19, Drug Manufacturing and Innovation
- Inspecting the Unexpected
- CureVac and Wacker Sign Contract for Manufacturing of Covid-19 Vaccine Candidate
- Lonza and Be The Match BioTherapies Enter CGT Partnership
- Samsung Biologics Breaks Ground on 'Super Plant'
- ApiJect Systems Approved for $590 Million Loan
- Syngene and 3DC Sign 5-year Collaboration
- Abenza Upgrades Chemistry GMP Suites
- Merck Acquires OncoImmune for $425M
- Baxter Invests $50M to Expand Sterile Fill/Finish Manufacturing Operations
- AstraZeneca’s AZD1222 Meets Primary Endpoint in COVID-19
- Regeneron's COVID-19 Antibody Cocktail Gets EUA
November/December 2020
- Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
- Ensuring Quality During the Transfer and Scale Up of Rx Drugs
- Inspecting the Unexpected
- Cold Chain Trends
- Catering for the Complex
- Biopharma Contract Manufacturing: Robust Growth Ahead
- DCAT President Talks COVID-19, Drug Manufacturing and Innovation
- The Single-Use Mixing Landscape: Evaluating Your Options
- Self-Medication: Flexibility for Patients and Drug Manufacturers
- Decentralized Trials Fuel AI Revolution in Clinical Research
Contract Service Directory
Search the Directories for A Company:
Trending
- Baxter Invests $50M To Expand Sterile Fill/Finish Manufacturing Operations
- CureVac And Wacker Sign Contract For Manufacturing Of Covid-19 Vaccine Candidate
- Delpharm To Manufacture Pfizer/BioNTech MRNA Vax In France
- AstraZeneca’s AZD1222 Meets Primary Endpoint In COVID-19
- Catalent, Blueprint Enter GAVRETO Commercial Supply Pact
